Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies

Stopped early · Phase 2

Conditions studied: Sickle Cell Anemia, Hemoglobinopathy, Thalassemia

In brief

The major goal of this study is to determine the risks and benefits of bone marrow transplants in patients with severe thalassemia or sickle cell disease. Participation in this project will be for two years.

Key facts

Study ID

NCT00040469

Run by

Baylor College of Medicine

People needed

15

Starts

2000-08-01

Expected to finish

2003-11-21

Last updated by the study team

2020-01-18

Who can join

Age: 0 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Texas Children's Hospital — Houston, Texas, United States
• The Methodist Hospital — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.